Simple Summary Several anti-angiogenic drugs have been approved for cancer treatment,
alone or in combination with other anti-tumoral agents. Angiogenesis inhibitors cause drug …

The growth and development of cancer are directly correlated to the suppression of the
immune system. A major breakthrough in cancer immunotherapy depends on various …

Pancreatic cancer is one of the most malignant tumors with increased incidence rate. The
effect of surgery combined with chemoradiotherapy on survival of patients is unsatisfactory …

Mast cells play a critical role in inflammatory diseases and tumor growth. The versatility of
mast cells is reflected in their ability to secrete a wide range of biologically active cytokines …

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal malignancy with a
high rate of recurrence and a dismal 5‐year survival rate. Contributing to the poor prognosis …

Simple Summary Pancreatic cancer is a serious ongoing global health burden, with an
overall 5-year survival rate of less than 5%. One major hurdle in the treatment of this disease …

Although the patient's survival time in various cancers has significantly increased in recent
decades, the overall 5-year survival rate of pancreatic ductal adenocarcinoma (PDAC) has …

Simple Summary Tumors from pancreatic cancer contain many types of cells (such as
immune cells and fibroblasts) in addition to the cancer cells. Using targeted drugs to disrupt …

The gut microbiome plays a significant role in the pathogenesis of pancreatic ductal
adenocarcinoma (PDAC), influencing oncogenesis, immune responses, and treatment …

Autophagy is conserved cellular machinery that degrades un-usable proteins and cellular
components and has a crucial role in the pathogenesis and drug resistance of various …